Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
10.1 USD | +3.38% | +1.46% | +0.15% |
05-02 | Transcript : Vir Biotechnology, Inc., Q1 2024 Earnings Call, May 02, 2024 | |
05-02 | Earnings Flash (VIR) VIR BIOTECHNOLOGY Reports Q1 Revenue $56.4M, vs. Street Est of $11.7M | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+0.15% | 1.33B | |
+27.40% | 48.16B | |
-0.94% | 41.73B | |
+43.45% | 41.03B | |
-5.26% | 28.77B | |
+10.22% | 25.59B | |
-22.89% | 18.96B | |
+8.07% | 12.92B | |
+29.29% | 12.03B | |
-2.07% | 11.77B |
- Stock Market
- Equities
- VIR Stock
- News Vir Biotechnology, Inc.
- Vir Biotechnology, VBI Vaccines Release Data Supporting Brii Biosciences Medical Assets in Treating Hepatitis B